Background: Bleeding from esophageal varices is a life-threatening complication of chronic portal hypertension (PH), occuring in 15% of patients with a mortality rate between 20 and 35%. Methods: Based on a literature review and personal experience in the therapy of PH, we recommend a therapy strategy for the secondary prophylaxis of variceal bleeding in PH. Results: The main causes for PH in western countries are alcoholic/viral liver cirrhosis and extrahepatic portal/mesenteric vein occlusion, mainly caused by myeloproliferative neoplasms or hypercoagulability syndromes. The primary therapy is medical; however, when recurrent bleeding occurs, a definitive therapy is required. In the case of parenchymal decompensation, liver transplantation is the causal therapy, but in case of good hepatic reserve or without underlying liver disease, a portal decompressive therapy is necessary. Transjugular intrahepatic portosystemic shunt has achieved a widespread acceptance, although evidence is comparable with or better for surgical shunting procedures in patients with good liver function. The type of surgical shunt should be chosen depending on the patent veins of the portovenous system and the personal expertise. Conclusion: The therapy decision should be based on liver function, morphology of the portovenous system, and imminent liver transplantation and should be made by an interdisciplinary team of gastroenterologists, interventional radiologists, and visceral surgeons.

Keywords:
Portal hypertension, Portal/mesenteric vein thrombosis, Surgical portocaval shunt, Cirrhosis, Esophageal varices
1.
Berzigotti A, Seijo S, Reverter E, Bosch J: Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013;7:141-155.
2.
Okuda K, Ohnishi K, Kimura K, et al: Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985;89:279-286.
3.
Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F: Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-697.
4.
Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A: Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007;102:2464-2470.
5.
de Franchis R; Baveno V Faculty: Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-768.
6.
Jensen DM: Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002;122:1620-1630.
7.
Sharara AI, Rockey DC: Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345:669-681.
8.
D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-354.
9.
Costa G, Cruz RJ Jr, Abu-Elmagd KM: Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am 2010;90:891-905.
10.
Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J: Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006;130:1643-1651.
11.
Rossle M: TIPS: 25 years later. J Hepatol 2013;59:1081-1093.
12.
Rosemurgy AS, Molloy DL, Thometz DP, Villadolid DV, Cowgill SM, Zervos EE: TIPS in Florida: is its application a result of evidence-based medicine? J Am Coll Surg 2007;204:794-801.
13.
Wolff M, Hirner A: Surgical treatment of portal hypertension (article in German). Zentralbl Chir 2005;130:238-245.
14.
Puhl G, Gul S, Neuhaus P: Portosystemic shunt surgery between TIPS and liver transplantation (article in German). Chirurg 2011;82:898-905.
15.
Khaitiyar JS, Luthra SK, Prasad N, Ratnakar N, Daruwala DK: Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt - a comparative study. Hepatogastroenterology 2000;47:492-497.
16.
Helton WS, Maves R, Wicks K, Johansen K: Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001;136:17-20.
17.
Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB: Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg 2012;214:445-453.
18.
Orloff MJ: Fifty-three years' experience with randomized clinical trials of emergency portacaval shunt for bleeding esophageal varices in Cirrhosis: 1958-2011. JAMA Surg 2014;149:155-169.
19.
Darwish MS, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL: Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167-175.
20.
Graham DY, Smith JL: The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-809.
21.
D'Amico G, de Franchis R; Cooperative Study Group: Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612.
22.
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR: A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
23.
Castera L, Pinzani M, Bosch J: Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012;56:696-703.
24.
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD: Liver biopsy. Hepatology 2009;49:1017-1044.
25.
Trebicka J, Strassburg CP: Etiology and complications of portal vein thrombosis. Viszeralmedizin 2014;30:■■-■■.
26.
Primignani M: Portal vein thrombosis, revisited. Dig Liver Dis 2010;42:163-170.
27.
Valla DC, Condat B: Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-871.
28.
Burroughs AK, Mezzanotte G, Phillips A, McCormick PA, McIntyre N: Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989;9:801-807.
29.
Rikkers LF, Jin G, Langnas AN, Shaw BW Jr: Shunt surgery during the era of liver transplantation. Ann Surg 1997;226:51-57.
30.
de Franchis R, Primignani M: Endoscopic treatments for portal hypertension. Semin Liver Dis 1999;19:439-455.
31.
Khan S, Tudur SC, Williamson P, Sutton R: Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev 2006;(4):CD000553.
32.
Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mossner J, Bosch J: Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370-2379.
33.
Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, Edwards RD, Robertson IR, Rose JD, Moss JG: Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004;15:1219-1230.
34.
Tripathi D, Helmy A, Macbeth K, Balata S, Lui HF, Stanley AJ, Redhead DN, Hayes PC: Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol 2004;16:9-18.
35.
Orloff MJ, Orloff MS, Girard B, Orloff SL: When is liver transplant indicated in cirrhosis with bleeding varices? Transplant Proc 2001;33:1366.
36.
Henderson JM, Nagle A, Curtas S, Geisinger M, Barnes D: Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery 2000;128:540-547.
37.
Khanna R, Sarin SK: Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 2014;60:421-441.
38.
Condat B, Pessione F, Helene DM, Hillaire S, Valla D: Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32:466-470.
39.
Wolff M, Hirner A: Current state of portosystemic shunt surgery. Langenbecks Arch Surg 2003;388:141-149.
40.
Clark W, Hernandez J, McKeon B, Villadolid D, Al-Saadi S, Mullinax J, Ross SB, Rosemurgy AS: Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surg 2010;76:857-864.
41.
Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D: Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010;25:1718-1725.
42.
Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP: Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007;27:742-747.
43.
Vignali C, Bargellini I, Grosso M, Passalacqua G, Maglione F, Pedrazzini F, Filauri P, Niola R, Cioni R, Petruzzi P: TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 2005;185:472-480.
44.
Wu Q, Jiang J, He Y, Jiang T, Zhou S: Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent. Exp Ther Med 2013;5:263-266.
45.
Clark W, Golkar F, Luberice K, Toomey P, Paul H, Marcadis A, Okpaleke C, Vice M, Hernandez J, Alsina A, Rosemurgy AS: Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts? Am J Surg 2011;202:561-564.
46.
Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-Radosavljevic M: Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003;38:1043-1050.
47.
Fanelli F, Angeloni S, Salvatori FM, Marzano C, Boatta E, Merli M, Rossi P, Attili AF, Ridola L, Cerini F, Riggio O: Transjugular intrahepatic portosystemic shunt with expanded-polytetrafluoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Dig Liver Dis 2011;43:78-84.
48.
Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Gonzales AJ, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J: TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135:808-815.
49.
Clavien PA, Selzner M, Tuttle-Newhall JE, Harland RC, Suhocki P: Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surg 1998;227:440-445.
50.
Rosemurgy AS, Zervos EE: Management of variceal hemorrhage. Curr Probl Surg 2003;40:263-343.
51.
Wolff M, Kalff JC, Textor J, Hirner A: Surgery for portal hypertension and transjugular intrahepatic portosystemic shunts in Germany: results of a national survey. Chirurg 1999;70:447-452.
52.
Rosemurgy AS, Bloomston M, Clark WC, Thometz DP, Zervos EE: H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 2005;241:238-246.
53.
Mitra SK, Rao KL, Narasimhan KL, Dilawari JB, Batra YK, Chawla Y, Thapa BR, Nagi B, Walia BN: Side-to-side lienorenal shunt without splenectomy in noncirrhotic portal hypertension in children. J Pediatr Surg 1993;28:398-401; discussion 401-402.
54.
Mercado MA, Orozco H, Guillen-Navarro E, Acosta E, Lopez-Martinez LM, Hinojosa C, Hernandez J, Tielve M: Small-diameter mesocaval shunts: a 10-year evaluation. J Gastrointest Surg 2000;4:453-457.
55.
Paquet KJ, Lazar A, Koussouris P, Hotzel B, Gad HA, Kuhn R, Kalk JF: Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br J Surg 1995;82:199-203.
56.
di Francesco F, Grimaldi C, de Ville de Goyet J: Meso-Rex bypass - a procedure to cure prehepatic portal hypertension: the insight and the inside. J Am Coll Surg 2014;218:e23-e36.
57.
Orozco H, Mercado MA, Takahashi T, Hernandez-Ortiz J, Capellan JF, Garcia-Tsao G: Elective treatment of bleeding varices with the Sugiura operation over 10 years. Am J Surg 1992;163:585-589.
58.
Orozco H, Mercado MA: The evolution of portal hypertension surgery: lessons from 1000 operations and 50 years' experience. Arch Surg 2000;135:1389-1393.
© 2015 S. Karger GmbH, Freiburg
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.